1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Human Valvular Interstitial Cells (VICs), the predominant cellular constituents within the heart valve, are ubiquitously distributed across its three distinct layers: the fibrosa, spongiosa, and ventricularis. These cells fulfill a pivotal role in the maintenance of valvular structural integrity. In response to pathological stimuli, valve tissue exhibits a pronounced accumulation of VICs, often concomitant with the infiltration of inflammatory cells, neovascularization, heightened extracellular matrix deposition, and subsequent fibrosis and calcification. Morphologically, VICs exhibit a hybrid phenotype, displaying characteristics reminiscent of both fibroblasts and smooth muscle cells, reflecting their multifaceted functional roles within the heart valve.
Why choose Human Valvular Interstitial Cells from AcceGen?
AcceGen’s Human Valvular Interstitial Cells (VICs) are derived from healthy human valves, cryopreserved at passage one, and delivered in a frozen state, with each vial containing over 0.5×106 viable cells. These cells are guaranteed to expand for 10 population doublings when following AcceGen’s instructions and have been rigorously tested for mycoplasma, bacteria, yeast, and fungi, ensuring their quality and reliability for research purposes.
Species | Human |
Cat.No | ABC-TC3866 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Interstitial Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Cardiac Cells |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
Human Valvular Interstitial Cells (VICs) serve as invaluable in vitro experimental systems, offering a platform for modeling various aspects of valve biology and pathobiology. Their application aids in shedding light on the intricate facets of VIC pathobiology, enhancing our comprehension of cellular heterogeneity regulation concerning valve structure and function in both healthy and diseased states. VICs thus stand as essential tools for advancing our knowledge of heart valve dynamics and disease mechanisms.
These cells are derived from the heart valve tissue of healthy human donors or patients undergoing surgery.
Yes, these cells are commonly used for studying valve-related diseases, fibrosis, and calcification.
These cells should be cultured in a fibroblast-specific medium with growth supplements to maintain viability.
Yes, they are suitable for preclinical drug testing aimed at treating or preventing valvular diseases.